| Net Cash Provided by (Used in) Operating Activities |
322K |
USD |
-50% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-1.61M |
USD |
-40% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
679K |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
4.59M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-606K |
USD |
+48.2% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
3.61K |
USD |
-83.6% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
8.19M |
USD |
+4.49% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
38.4K |
USD |
-45.6% |
Q1 2025 |
Q1 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
84.1K |
USD |
-40.3% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
1.39K |
USD |
+82.6% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
420K |
USD |
-60.5% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
25K |
USD |
+5.56% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
612K |
USD |
+25.7% |
Q4 2024 |
FY 2024 |